Profil

Avatar

Blagoje Murganić

Zvanje:
Istraživač saradnik
Direktni telefoni:
Lokal:
Naučna oblast:
1
Veće oblasti:
Orcid broj:
Organizaciona jedinica:
080

M faktor

Kategorija Broj Koeficijent Ukupno

Ukupno M faktor:

0
--> -->--> -->--> --> --> -->--> -->--> --> -->-->

NI radovi

# Naziv, Datum, Grupa, Vrsta Godina Autori Status
1 Carborane-Based Analogues of 5-Lipoxygenase Inhibitors Co-inhibit Heat Shock Protein 90 in HCT116 Cells
ChemMedChem , , 2018
M20 | M21
2018 Dr. Robert Kuhnert, Dr. Menyhárt-Botond Sárosi, Sven George, Dr. Peter Lönnecke, Dr. Bettina Hofmann, Prof. Dr. Dieter Steinhilber, Sara Steinmann, Prof. Dr. Regine Schneider-Stock, Blagoje Murganić, Prof. Dr. Sanja Mijatović, Prof. Dr. Danijela Maksimović-Ivanić, Prof. Dr. Dr. h.c. mult. Evamarie Hey-Hawkins
Odobren
2 Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells
Scientific Reports , , 2020
M20 | M21
2020 Antonio Buzharevski, Svetlana Paskaš, Menyhárt-Botond Sárosi, Markus Laube, Peter Lönnecke, Wilma Neumann, Blagoje Murganić, Sanja Mijatović, Danijelа Maksimović-Ivanić, Jens Pietzsch & Evamarie Hey-Hawkins
Odobren
3 CarbORev-5901: The First Carborane-Based Inhibitor of the 5-Lipoxygenase Pathway
ChemMedChem , , 2017
M20 | M21
2017 MSc. Robert Kuhnert, Dr. Menyhárt-Botond Sárosi, Sven George, Dr. Peter Lönnecke, Dr. Bettina Hofmann, Prof. Dr. Dieter Steinhilber, Blagoje Murganic, Prof. Dr. Sanja Mijatovic, Prof. Dr. Danijela Maksimovic-Ivanic, Prof. Dr. Dr. h.c. mult. Evamarie Hey-Hawkins
Odobren
4 Carborane-Based Analog of Rev-5901 Attenuates Growth of Colon Carcinoma In Vivo
Molecules , , 2022
M20 | M22
2022 Svetlana Paskaš, Blagoje Murganić, Robert Kuhnert, Evamarie Hey-Hawkins, Sanja Mijatović, Danijela Maksimović-Ivanić
Odobren
5 Carboranyl Analogues of Ketoprofen with Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines
ACS omega , , 2019
M20 | M22
2019 Antonio BuzharevskiAntonio Buzharevski Institut für Anorganische Chemie, Universität Leipzig, Johannisallee 29, D-04103 Leipzig, Germany More by Antonio Buzharevski , Svetlana Paskas, Markus Laube, Peter Lönnecke, Wilma Neumann, Blagoje Murganic, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Jens Pietzsch, and Evamarie Hey-Hawkins*
Odobren
6 Quinoline-Conjugated Ruthenacarboranes: Toward Hybrid Drugs with a Dual Mode of Action
ChemMedChem , , 2019
M20 | M22
2019 Gozzi M, Murganic B, Drača D, Popp J, Coburger P, Maksimović-Ivanić D, Mijatović S, Hey-Hawkins E
Odobren
7 TARGETING OF INFLAMMATION-CONNECTED TUMORS BY CARBORANECONJUGATED ROFECOXIB ANALOGS
IMMUNOLOGY AT THE CONFLUENCE OF MULTIDISCIPLINARY APPROACHES , Belgrade, Serbia , 2019
M30 | M34
2019 Blagoje Murganić , Antonio Buzharevski , Svetlana Paskaš , Menyhárt-Botond Sárosi , Markus Laube , Peter Lönnecke , Wilma Neumann , Sanja Mijatović , Jens Pietzsch, Evamarie Hey-Hawkins , Danijelа Maksimović-Ivanić
Odobren
8 Antitumorska svojstva inhibitora lipooksigenaze (LOX), REV5901
VII naučni sastanak Društva imunologa Srbije , Beograd, Srbija , 2016
M60 | M64
2016 Blagoje Murganić, Robert Kuhnert, Eva Hey-Hawkins, Sanja Mijatović, Danijela Maksimović-Ivanić
Odobren
9 DIFFERENCES IN CARBONIC ANHYDRASE 9 AND 12 EXPRESSION IN LUNG ADENOCARCINOMA AND LUNG SQUAMOUS CELL CARCINOMA
FIRST SERBIAN MOLECULAR MEDICINE CONGRESS , Foča , 2022
M30 | M34
2022 Milica Nedeljkovic, Jelena Stojisic , Nasta Tanic, Blagoje Murganic, Tijana Tomic, Nejla Ademovic, Nikola Tanic
Odobren
10 THE ROLE OF TP53 AND PTEN TUMOR SUPPRESSOR GENES IN RESPONSE TO DIFFERENT BREAST CANER TREATMENT MODALITES
FIRST SERBIAN MOLECULAR MEDICINE CONGRESS , Foča , 2022
M30 | M34
2022 Nikola Tanic, Tatjana Dramićanin, Zorka Milovanović, Milica Nedeljković, Tijana Tomić, Neja Ademović, Blagoje Murganić, Nasta Tanić
Odobren
11 Potential of Tamoxifen-based Copper(II) Dichloride in Breast Cancer Therapy
ONCOLOGY INSIGHTS , Beograd, Srbija , 2023
M30 | M34
2023 Blagoje Murganić, Aleksandar Kazimir, Sanja Jelača, Nikola Tanić, Nasta Tanić, Evamarie Hey-Hawkins, Sanja Mijatović, Danijela Maksimović-Ivanić
Odobren
12 Tamoxifen as a vector for platinum(II) and palladium(II) complexes in breast cancer treatment
The second serbian molecular medicine congress , Foča , 2023
M30 | M34
2023 Blagoje Murganić, Aleksandar Kazimir, Sanja Jelača, Nikola Tanić, Nasta Tanić, Evamarie Hey-Hawkins, Sanja Mijatović, Danijela Maksimović-Ivanić
Odobren
13 DETECTION OF GENOMIC INSTABILITY IN MALIGNANT BRAIN TUMORS
The Second Congress of Molecular Biologists of Serbia , Belgrade , 2023
M30 | M34
2023 Nejla Ademović, Nasta Tanić, Tijana Tomić, Blagoje Murganić, Marina Milić, Nikola Tanić
Odobren
14 Role of TP53 and PTEN tumor suppressor genes alterations in breast cancer response to therapy
THE FIFTH CONGRESS OF THE SERBIAN ASSOCIATION FOR CANCER RESEARCH - Translational potential of cancer research in Serbia , , 2021
M30 | M34
2021 Milica Nedeljković, Tatjana Dramićanin, Mirjana Prvanović, Blagoje Murganić, Tijana Tomić, Neila Ademović, Zorka Milovanović, Nikola Tanić, Nasta Tanić
Odobren
15 The impact of TP53 and PTEN tumor suppressor genes on response to different breast cancer treatment modalities
Биомедицинска истраживања , , 2022
M50 | M52
2022 Nikola Tanić, Tatjana Dramićanin, Nejla Ademović, Tijana Tomić, Blagoje Murganić, Zorka Milovanović, Milica Nedeljković, Nasta Tanić
Odobren

Citati

Broj citata Referenca Status
Link | Dokument
Odobren